Staphylococcal infection vaccine - aVaxziPen/Unknown company
Latest Information Update: 19 Oct 2023
At a glance
- Originator Enesi Pharma
- Developer aVaxziPen
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Staphylococcal infections
Most Recent Events
- 12 Sep 2020 Enesi Pharma collaborates with an undisclosed company to develop a Staphylococcal infection vaccine (Enesi Pharma pipeline, September 2020)
- 09 Sep 2020 Early research in Staphylococcal infections (Prevention) in United Kingdom (Transdermal) (Enesi Pharma pipeline, September 2020)
- 28 May 2020 Enesi Pharma has patent protection for single-use cassette assembly for use in a reusable solid dose formulation delivery actuator device worldwide